隨著 DeSci 勢頭的增強，SUI DeSci Agent 宣布專案啟動

SUI DeSci Agent 是一個旨在幫助零售受眾注入長壽研究突破的平台，該平台已宣布啟動其項目

Retail audiences can now enjoy direct access to longevity research breakthroughs with the launch of SUI DeSci Agents, a platform that is set to revolutionize the DeSci landscape.

隨著 SUI DeSci Agents 的推出，零售受眾現在可以直接獲得長壽研究突破，該平台將徹底改變 DeSci 格局。

According to an official announcement on Friday, the platform’s launch comes as part of a broader effort to provide retail users with exclusive and democratized access to longevity research. This development positions SUI DeSci Agents as a leading project within the rapidly evolving DeSci space.

根據週五的官方公告，該平台的推出是為零售用戶提供獨家和民主化的長壽研究機會的更廣泛努力的一部分。這項開發使 SUI DeSci Agents 成為快速發展的 DeSci 領域的領先項目。

As part of its design, SUI DeSci Agents is dedicated to launching DeSci assets, expanding their audience through AI agents, and generating liquidity through advanced mechanics inspired by pump.fun.

作為其設計的一部分，SUI DeSci Agents 致力於推出 DeSci 資產，透過人工智慧代理擴大受眾，並透過受 Pump.fun 啟發的先進機制產生流動性。

Coinciding with its entry into the DeSci ecosystem, the launch also introduces the platform's native token, $DESCI. This token will grant users access to a range of unique features, including tokenized compounds, pluggable AI agents, layer-2 liquidity mechanics, and AI-powered B2C products.

在進入 DeSci 生態系統的同時，此次發布也推出了該平台的原生代幣 $DESCI。該代幣將允許用戶存取一系列獨特的功能，包括代幣化化合物、可插入的人工智慧代理、第 2 層流動性機制和人工智慧驅動的 B2C 產品。

With these features, users can wager on the potential of longevity compounds, such as Epitalon and Rapamycin (the first compounds to be launched), by analyzing their scientific data and statistics. The project also pairs LLM-trained AI agents with longevity compounds, engaging them in 24/7 promotion across social platforms to ensure optimal outreach.

借助這些功能，使用者可以透過分析科學數據和統計數據來押注長壽化合物的潛力，例如 Epitalon 和雷帕黴素（第一個推出的化合物）。該計畫還將受過法學碩士培訓的人工智慧代理商與長壽化合物配對，讓他們在社交平台上進行 24/7 的推廣，以確保最佳的推廣。

Significantly, the platform aims to establish a robust liquidity ecosystem tailored for DeSci, fostering organic growth and supporting the broader ecosystem.

值得注意的是，該平台旨在建立一個專為 DeSci 量身定制的強大的流動性生態系統，促進有機成長並支援更廣泛的生態系統。

DeSci's Potential as the Next Major Trend For 2025

DeSci 預計將成為 2025 年下一個主要趨勢

Emerging rapidly to address systemic inefficiencies in traditional scientific research, such as bureaucratic funding processes, underfunded breakthrough opportunities, and limited retail access to longevity investments, DeSci has garnered increasing attention.

DeSci 迅速崛起，旨在解決傳統科學研究中的系統性低效率問題，例如官僚融資流程、資金不足的突破機會以及零售長壽投資的管道有限，它引起了越來越多的關注。

This momentum was further propelled by key leaders, including Vitalik Buterin, who highlighted the transformative potential of DeSci projects at the recent Devcon event.

這一勢頭得到了關鍵領導人的進一步推動，其中包括 Vitalik Buterin，他在最近的 Devcon 活動上強調了 DeSci 項目的變革潛力。

In other developments, Coinbase founder Brian Armstrong expressed support for ResearchHub to foster open scientific collaboration. A16Z also led a $5M funding round for AminoChain, a decentralized biosample marketplace.

在其他進展中，Coinbase 創辦人 Brian Armstrong 表示支持 ResearchHub 促進開放的科學合作。 A16Z 也領投了去中心化生物樣本市場 AminoChain 的 500 萬美元融資。

Moreover, Pfizer Ventures participated in a $4.1M funding round of VitaDAO, a project focused on raising funds for research that expands human lifespan.

此外，輝瑞創投公司也參與了 VitaDAO 的 410 萬美元融資，該計畫專注於為延長人類壽命的研究籌集資金。

As DeSci continues to gain steam, SUI DeSci Agents is aiming to create a platform where retail audiences can invest in tokenized longevity compounds. The project will also introduce AI-powered B2C wellness tools to assist SUI Desci Agents in onboarding more users into the ecosystem.

隨著 DeSci 的不斷發展，SUI DeSci Agents 的目標是創建一個平台，讓零售受眾可以投資代幣化的長壽化合物。該計畫還將引入人工智慧驅動的 B2C 健康工具，以協助 SUI Desci Agents 吸引更多用戶進入生態系統。